Arkolith/Insider Trading/EVFM/Form 4

Fitzpatrick Alexander A

General Counsel and SecretaryEvofem Biosciences, Inc. (EVFM) · full profile →Form 4 · filed Jan 4, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 31, 2021Disposed to issuer(D)120K—$0216K

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001618835-22-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML